These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8946471)

  • 21. Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.
    Saxena R; Shaw GL; Relling MV; Frame JN; Moir DT; Evans WE; Caporaso N; Weiffenbach B
    Hum Mol Genet; 1994 Jun; 3(6):923-6. PubMed ID: 7951238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6.
    Zanger UM; Fischer J; Raimundo S; Stüven T; Evert BO; Schwab M; Eichelbaum M
    Pharmacogenetics; 2001 Oct; 11(7):573-85. PubMed ID: 11668217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of (+/-)-bufuralol hydroxylation activities in liver microsomes of Japanese and Caucasian subjects genotyped for CYP2D6.
    Shimada T; Tsumura F; Yamazaki H; Guengerich FP; Inoue K
    Pharmacogenetics; 2001 Mar; 11(2):143-56. PubMed ID: 11266079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
    Sachse C; Brockmöller J; Bauer S; Roots I
    Am J Hum Genet; 1997 Feb; 60(2):284-95. PubMed ID: 9012401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cytochrome P450 CYP2D6 allelic variant CYP2D6J and related polymorphisms in a European population.
    Armstrong M; Fairbrother K; Idle JR; Daly AK
    Pharmacogenetics; 1994 Apr; 4(2):73-81. PubMed ID: 8081414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpretation of a simple PCR analysis of the CYP2D6(A) and CYP2D6(B) null alleles associated with the debrisoquine/sparteine genetic polymorphism.
    Douglas AM; Atchison BA; Somogyi AA; Drummer OH
    Pharmacogenetics; 1994 Jun; 4(3):154-8. PubMed ID: 7920695
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype.
    Daly AK; Fairbrother KS; Andreassen OA; London SJ; Idle JR; Steen VM
    Pharmacogenetics; 1996 Aug; 6(4):319-28. PubMed ID: 8873218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes.
    Kubota T; Yamaura Y; Ohkawa N; Hara H; Chiba K
    Br J Clin Pharmacol; 2000 Jul; 50(1):31-4. PubMed ID: 10886115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Debrisoquine and S-mephenytoin hydroxylation phenotypes and genotypes in a Korean population.
    Roh HK; Dahl ML; Johansson I; Ingelman-Sundberg M; Cha YN; Bertilsson L
    Pharmacogenetics; 1996 Oct; 6(5):441-7. PubMed ID: 8946476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent occurrence of CYP2D6*10 duplication allele in a Japanese population.
    Mitsunaga Y; Kubota T; Ishiguro A; Yamada Y; Sasaki H; Chiba K; Iga T
    Mutat Res; 2002 Aug; 505(1-2):83-5. PubMed ID: 12175908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphism of CYP2D6 in the Japanese population.
    Chida M; Yokoi T; Kosaka Y; Chiba K; Nakamura H; Ishizaki T; Yokota J; Kinoshita M; Sato K; Inaba M; Aoki Y; Gonzalez FJ; Kamataki T
    Pharmacogenetics; 1999 Oct; 9(5):601-5. PubMed ID: 10591540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cytochrome P450 2D6 (CYP2D6) gene polymorphism among breast and head and neck cancer patients.
    Topić E; Stefanović M; Ivanisević AM; Petrinović R; Curcić I
    Clin Chim Acta; 2000 Jun; 296(1-2):101-9. PubMed ID: 10807974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population.
    Griese EU; Zanger UM; Brudermanns U; Gaedigk A; Mikus G; Mörike K; Stüven T; Eichelbaum M
    Pharmacogenetics; 1998 Feb; 8(1):15-26. PubMed ID: 9511177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer status.
    Gaedigk A; Bradford LD; Alander SW; Leeder JS
    Drug Metab Dispos; 2006 Apr; 34(4):563-9. PubMed ID: 16415111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Debrisoquine polymorphism: novel CYP2D6 gene Bam HI restriction fragment length polymorphism in the Ngawbé Guaymí Indian of Panama.
    Petersen DD; Kong AN; Jorge LF; Nebert DW; Arias TD
    Pharmacogenetics; 1991 Dec; 1(3):136-42. PubMed ID: 1688244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.
    Yokoi T; Kamataki T
    Pharm Res; 1998 Apr; 15(4):517-24. PubMed ID: 9587945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6.
    Wang SL; Huang JD; Lai MD; Liu BH; Lai ML
    Clin Pharmacol Ther; 1993 Apr; 53(4):410-8. PubMed ID: 8097442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP2D7-2D6 hybrid tandems: identification of novel CYP2D6 duplication arrangements and implications for phenotype prediction.
    Gaedigk A; Fuhr U; Johnson C; Bérard LA; Bradford D; Leeder JS
    Pharmacogenomics; 2010 Jan; 11(1):43-53. PubMed ID: 20017671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes.
    Kagimoto M; Heim M; Kagimoto K; Zeugin T; Meyer UA
    J Biol Chem; 1990 Oct; 265(28):17209-14. PubMed ID: 2211621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotype and allele frequency of CYP2D6 in Tamilian population.
    Adithan C; Gerard N; Naveen AT; Koumaravelou K; Shashindran CH; Krishnamoorthy R
    Eur J Clin Pharmacol; 2003 Oct; 59(7):517-20. PubMed ID: 12942225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.